Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

NCT06412718 is registered in ClinicalTrials.gov with IRCCS Ospedale San Raffaele as lead sponsor.

NCT NCT06412718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06412718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
Lead sponsor
IRCCS Ospedale San Raffaele
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2024
Completion date
April 30, 2026
Enrollment
274 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aniridia, corneal neovascularization, eec syndrome, limbal stem cell deficiency, neurotrophic keratopathy, ocular cicatricial pemphigoid, ocular graft-versus-host disease, rare diseases